(2R,3R,11Br)-1,3,4,6,7,11B-Hexahydro-9,10-Dimethoxy-3-(2-Methylpropyl)-2H-Benzo[A]Quinolizin-2-Ol

3 trials 2 recruiting

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

0 Completed trials

1 Sponsors

5 Countries

Phase II

Phase II: 3

Oversight events:

1 temporary halt across 1 trial

View oversight register →

Indications tested

Tardive dyskinesia 3

Sponsors using this IMP

Adeptio Pharmaceuticals Limited 3

All trials

3 total

An Open label, Safety Clinical trial of (+)-α-dihydrotetrabenazine in patients with moderate to severe tardive dyskinesia Recruiting

2023-509518-12-01 Phase II 2 countries Adeptio Pharmaceuticals Limited
Clinical trial of (+)-α-dihydrotetrabenazine in patients with moderate to severe tardive dyskinesia with open-label Part I and randomized, d… Recruiting

2024-516852-17-00 Phase II 4 countries Adeptio Pharmaceuticals Limited
Evaluate the Efficacy, Safety and Tolerability of (+)-α-dihydrotetrabenazine for Treatment of Tardive Dyskinesia Halted

2024-519105-35-00 Phase II 1 country Adeptio Pharmaceuticals Limited

Showing 1–3 of 3 trials

← All drugs A–Z